A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Clinical trial NCT05019521 · TERMINATED
Trial details
- NCT number
- NCT05019521
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-23
- Primary completion
- 2024-07-05
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.